In February, Dr. Souweidane attended the Alicia Pueyo Workshop on DIPG in Barcelona, where he presented an update on the use of convection-enhanced delivery (CED) for DIPG to an international audience of scientists, clinicians, and family advocates. As Dr. Souweidane’s clinical trial approaches completion, other groups are highly interested in learning more about CED, as evidenced by the invitations he has received to present this innovative strategy: as a keynote speaker at the University of Alabama Birmingham/Children’s Hospital of Alabama for its annual Pediatric Neuro-oncology Symposium on May 1, at the DIPG Collaborative Symposium in April in Chicago, and as the 2015 E. Bruce Hendrick Visiting Professor at the University of Toronto/Hospital for Sick Children on May 22.
In March, an unprecedented constellation of scientists and oncologists met in Paris to discuss the status of diagnosis, treatment, and scientific inquiry into gliomatosis cerebri (GC), a disease so close to many of us at the CBTP. Dr. Greenfield cohosted the two-day gathering, which took place at the Institut Curie. Developments included an agreement that Weill Cornell will host the International GC Registry with back-end analytic support from the DIPG community. The ICB in London and Weill Cornell in New York were also selected as the European and North American sites for sample collection and comprehensive genomic analyses. The panel discussed new scientific projects to focus on and the concept of a GC-specific clinical trial within two years. This cross-continental initiative is truly a remarkable example of the efforts that can result from collaboration and synergy.